April 8, 2022
SARC032 Expanded
SU2C has made additional funds available for SARC032 so that we can increase the sample size and power of this randomized, ongoing trial from 102 to 126 evaluable patients. SARC032 …
Read moreYear: 2022
March 8, 2022
Now Recruiting: CHIEF MEDICAL OFFICER
SARC is seeking a part-time Chief Medical Officer (CMO). The CMO (a newly created role for SARC) will work in partnership with the Chief Executive Officer (CEO) and Chief Scientific …
Read moreFebruary 15, 2022
Together We Can Change Patient Outcomes
The Sarcoma field is small, and the need for fostered collaborations is critical. Learn about our 2022 fundraising goals and explore how you can partner with us.
Read more